Colgate-Palmolive Company $CL Shares Sold by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. trimmed its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 5.2% during the second quarter, Holdings Channel.com reports. The firm owned 181,862 shares of the company’s stock after selling 9,904 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in Colgate-Palmolive were worth $16,622,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of the stock. Brighton Jones LLC raised its position in shares of Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after buying an additional 450 shares in the last quarter. J.W. Cole Advisors Inc. boosted its holdings in shares of Colgate-Palmolive by 65.0% in the first quarter. J.W. Cole Advisors Inc. now owns 25,402 shares of the company’s stock valued at $2,380,000 after acquiring an additional 10,005 shares in the last quarter. Teachers Retirement System of The State of Kentucky increased its stake in shares of Colgate-Palmolive by 4.4% during the first quarter. Teachers Retirement System of The State of Kentucky now owns 63,170 shares of the company’s stock valued at $5,919,000 after acquiring an additional 2,668 shares during the period. Wealth Alliance LLC increased its stake in shares of Colgate-Palmolive by 5.5% during the first quarter. Wealth Alliance LLC now owns 4,147 shares of the company’s stock valued at $389,000 after acquiring an additional 216 shares during the period. Finally, Crestwood Advisors Group LLC raised its holdings in Colgate-Palmolive by 3.6% during the first quarter. Crestwood Advisors Group LLC now owns 35,623 shares of the company’s stock worth $3,338,000 after purchasing an additional 1,253 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.7%

NYSE:CL opened at $79.37 on Wednesday. The stock has a fifty day simple moving average of $78.98 and a 200 day simple moving average of $85.00. The firm has a market capitalization of $63.98 billion, a price-to-earnings ratio of 22.29, a price-to-earnings-growth ratio of 4.44 and a beta of 0.35. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.17 billion. During the same period in the prior year, the firm earned $0.91 earnings per share. The business’s quarterly revenue was up 1.9% on a year-over-year basis. Sell-side analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 14th. Investors of record on Friday, October 17th were given a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. The ex-dividend date was Friday, October 17th. Colgate-Palmolive’s dividend payout ratio is 58.26%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on CL shares. Deutsche Bank Aktiengesellschaft set a $86.00 price target on Colgate-Palmolive in a research report on Friday, October 10th. Raymond James Financial lowered their target price on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a report on Monday, October 20th. Piper Sandler initiated coverage on shares of Colgate-Palmolive in a research report on Friday, October 3rd. They issued a “neutral” rating and a $84.00 price target on the stock. Evercore ISI reduced their price objective on shares of Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating for the company in a research report on Monday, November 3rd. Finally, The Goldman Sachs Group dropped their target price on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a report on Thursday, October 2nd. Nine research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus target price of $89.87.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.